Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis

The efficacy of peroxisome proliferator-activated receptor α-agonists (e.g., fibrates) against nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) in humans is not known. Pemafibrate is a novel selective peroxisome proliferator-activated receptor α modulator that can maximiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Yasushi, Kessoku, Takaomi, Ogawa, Yuji, Tomeno, Wataru, Imajo, Kento, Fujita, Koji, Yoneda, Masato, Takizawa, Toshiaki, Saito, Satoru, Nagashima, Yoji, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307366/
https://www.ncbi.nlm.nih.gov/pubmed/28195199
http://dx.doi.org/10.1038/srep42477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307366/
https://www.ncbi.nlm.nih.gov/pubmed/28195199
http://dx.doi.org/10.1038/srep42477

Ejemplares similares